Evidence map›Paper›PMID 29535729›Full record

ReviewFrontiers in immunology2018

Epigenomic Modifications Mediating Antibody Maturation.

Emily C Sheppard, Rikke Brandstrup Morrish, Michael J Dillon, Rebecca Leyland, Richard Chahwan

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Role of Dot1L and H3K79 methylation in regulating somatic hypermutation of immunoglobulin genes.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Single Cell Imaging of Nuclear Architecture Changes.Frontiers in cell and developmental biology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Emily C SheppardLiving Systems Institute, University of Exeter, Exeter, United Kingdom.
Rikke Brandstrup MorrishLiving Systems Institute, University of Exeter, Exeter, United Kingdom.
Michael J DillonLiving Systems Institute, University of Exeter, Exeter, United Kingdom.
Rebecca LeylandSheffield Hallam University, Sheffield, United Kingdom.
Richard ChahwanLiving Systems Institute, University of Exeter, Exeter, United Kingdom.
University of Exeter · GBSheffield Hallam University · GB

Funding

Biotechnology and Biological Sciences Research Council BB/J014400/1Biotechnology and Biological Sciences Research Council BB/N017773/1
6 · The paper itself

Abstract

Epigenetic modifications, such as histone modifications, DNA methylation status, and non-coding RNAs (ncRNA), all contribute to antibody maturation during somatic hypermutation (SHM) and class-switch recombination (CSR). Histone modifications alter the chromatin landscape and, together with DNA primary and tertiary structures, they help recruit Activation-Induced Cytidine Deaminase (AID) to the immunoglobulin (Ig) locus. AID is a potent DNA mutator, which catalyzes cytosine-to-uracil deamination on single-stranded DNA to create U:G mismatches. It has been shown that alternate chromatin modifications, in concert with ncRNAs and potentially DNA methylation, regulate AID recruitment and stabilize DNA repair factors. We, hereby, assess the combination of these distinct modifications and discuss how they contribute to initiating differential DNA repair pathways at the Ig locus, which ultimately leads to enhanced antibody-antigen binding affinity (SHM) or antibody isotype switching (CSR). We will also highlight how misregulation of epigenomic regulation during DNA repair can compromise antibody development and lead to a number of immunological syndromes and cancer.

Indexed as

Immunoglobulin Class SwitchingSomatic Hypermutation, ImmunoglobulinAICDA (Activation-Induced Cytidine Deaminase)AnimalsChromatinCytidine DeaminaseDNA RepairEpigenesis, GeneticHistonesHumansImmune System DiseasesImmunity, HumoralNeoplasmsRNA, UntranslatedAICDA (Activation-Induced Cytidine Deaminase)ChromatinCytidine DeaminaseHistonesRNA, Untranslatedantibody diversityB cell maturationclass-switch recombinationcytosine deaminationepigenetic modificationsepigenomics and epigeneticssomatic hypermutation

Identifiers

PMID29535729
PMCPMC5834911
OpenAlexW2792313850

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.